Evoting Results along with Scrutinizer Report for the 43rd Annual General Meeting held on 30/09/2026

N atco Pharma Limited Regd. Off. : 'NATCO HOUSE', Road No. 2, Banjara Hills, Hyderabad • 500034. Telangana, INDIA. Tel : +91 40 23547532, Fax : +91 40 23548243 CIN : L24230TG 1981PLC003201, www.natcopharrna.co.in 30th September, 2026 Corporate Relationship Department The Manager - Listing M/s. BSE Limited M/s. National Stock Exchange of India Ltd Mumbai 400 001. Mumbai 400 051 Scrip Code: 524816 Scrip Code: NATCOPHARM Dear Sir Sub:- Voting Results of the 43rd Annual General Meeting In compliance with Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Members of the Company transacted the business as stated in Notice of 43rd Annual General Meeting dated 14th August, 2026: Sl. No. Description Particulars 1 Date of the Annual General Meeting 30th September, 2026 2 Total Number of Shareholders as on Cut-off date 4,22,879 I I (i.e., 25th September, 2026) The Agenda wise disclosure of voting details is enclosed as Annexure A. The Report of Scrutinizer on remote e-voting and e-voting during the Annual General Meeting is enclosed as Annexure B. We hereby affirm that none of the Director(s) of the Company appointed at the 43rd Annual General Meeting are debarred from holding the office of Director by virtue of any SEBI order or any other such authority. Thanking you, Yours faithfully, For NATCO Pharma Limited Ch. Venkat Ramesh Company Secretary & Compliance Officer Encl: as above Annexure - A NATCO Pharma Limited Details regarding Voting results: As per Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Resolution NO 1 Resolution Requried (Ordinary / Special ) Ordinary - Adoption of Audited Annual Financial Statements for the Financial year 2025-26 Whether promoter/ promoter group are interested NO in the agenda/resolution? Promoters /Public Mode of Voting Type No of Shares held N o o f V o t es % of Votes Polled No. of Votes in No of Votes - % of Votes in favour on % of Votes against on (1) Polled on shares held Favour A g a i n s t (5) Votes Polled Votes Polled (2) (3)=((2)/(1)*100) (4) (6)=((4)/(2)*100) (7)=((5)/(2)*100) Promoter and 88465126 87079540 98.43 87079540 0 100.00 0.00 Promoter Group Public- Institutional EVOTING 39863683 29104538 73.01 28855010 249528 99.14 0.86 Holders Public - Others 50781061 1228973 2.42 1219086 9887 99.20 0.80 Total 179109870 117413051 65.55 117153636 259415 99.78 0.22 Resolution NO 2 Resolution Requried (Ordinary / Special ) Ordinary - To Confirm three Interim Dividends agreegating to Rs.5/- per shares paid on equity shares during the Financial year 2025-26 as final dividend Whether promoter/ promoter group are interested NO in the agenda/resolution? Promoters /Public Mode of Voting Type No of Shares held N o o f V o t es % of Votes Polled No. of Votes in No of Votes - % of Votes in favour on % of Votes against on (1) Polled on shares held Favour A g a i n s t (5) Votes Polled Votes Polled (2) (3)=((2)/(1)*100) (4) (6)=((4)/(2)*100) (7)=((5)/(2)*100) Promoter and 88465126 87079540 98.43 87079540 0 100.00 0.00 Promoter Group Public- Institutional Holders EVOTING 39863683 29390395 73.73 29390395 0 100.00 0.00 Public - Others 50781061 2.42 1218916 10004 99.19 0.81 1228920 Total 179109870 117698855 65.71 117688851 10004 99.99 0.01 Annexure - A NATCO Pharma Limited Details regarding Voting results: As per Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Resolution NO 3 Resolution Requried (Ordinary / Special ) Ordinary - Re-appointment of Sri P.S.R.K. Prasad (DIN: 07011140) as a Director liable to retire by rotation Whether promoter/ promoter group are interested NO in the agenda/resolution? Promoters /Public Mode of Voting Type No of Shares held N o o f V o t es % of Votes Polled No. of Votes in No of Votes - % of Votes in favour on % of Votes against on (1) Polled on shares held Favour A g a i n s t (5) Votes Polled Votes Polled (2) (3)=((2)/(1)*100) (4) (6)=((4)/(2)*100) (7)=((5)/(2)*100) Promoter and 88465126 87079540 98.43 87079540 0 100.00 0.00 Promoter Group Public- Institutional Holders EVOTING 39863683 29385660 73.72 28729535 656125 97.77 2.23 Public - Others 50781061 1228470 2.42 1217565 10905 99.11 0.89 Total 179109870 117693670 65.71 117026640 667030 99.43 0.57 Resolution NO 4 Resolution Requried (Ordinary / Special ) Ordinary - Ratification of remuneration of Cost Auditors Whether promoter/ promoter group are interested NO in the agenda/resolution? Promoters /Public Mode of Voting Type No of Shares held N o o f V o t es % of Votes Polled No. of Votes in No of Votes - % of Votes in favour on % of Votes against on (1) Polled on shares held Favour A g a i n s t (5) Votes Polled Votes Polled (2) (3)=((2)/(1)*100) (4) (6)=((4)/(2)*100) (7)=((5)/(2)*100) Promoter and 88465126 87079540 98.43 87079540 0 100.00 0.00 Promoter Group Public- Institutional EVOTING Holders 39863683 29385660 73.72 29385660 0 100.00 0.00 Public - Others 50781061 1228429 2.42 1217063 11366 99.07 0.93 Total 179109870 117693629 65.71 117682263 11366 99.99 0.01 Annexure - A NATCO Pharma Limited Details regarding Voting results: As per Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Resolution NO 5 Resolution Requried (Ordinary / Special ) Special - To approve raising of funds in one or more tranches, by issuance of securities by way of preferential issue, rights issue, private placement (including qualified institutions placement(s)) and/or any combination thereof or any other method as may be permitted under applicable law for an amount not exceeding Rs. 2,000 crores Whether promoter/ promoter group are interested NO Promoters /Public Mode of Voting Type No of Shares held N o o f V o t es % of Votes Polled No. of Votes in No of Votes - % of Votes in favour on % of Votes against on (1) Polled on shares held Favour A g a i n s t (5) Votes Polled Votes Polled (2) (3)=((2)/(1)*100) (4) (6)=((4)/(2)*100) (7)=((5)/(2)*100) Promoter and 88465126 98.43 87079540 0 100.00 0.00 Promoter Group 87079540 Public- Institutional EVOTING Holders 39863683 73.73 28148289 1237371 95.77 4.21 29385660 Public - Others 50781061 1228890 2.42 1216758 12132 99.01 0.99 Total 179109870 117694090 65.71 116444587 1249503 98.94 1.06 Annexure B BK & Associates Flat No.502, 5 Floor, Vipanchi Residency, Lane Beside Paradise Company Secretaries Take Away, Masab Tank, Hyderabad -500 028, Telangana, India. � 040- 6677 2271, +9192937 12271 I +91 91000 80021, @ mail_bka@yahoo.com REPORT OF SCRUTINIZER !Pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 and Rule 21 of the Companies (Management and Administration) Rules, 2014] The Chairman Mis. Natco Pharma Limited Natco House, Road# 2, Banjara Hills, Hyderabad - 500 034. Dear Sir, Sub: Consolidated Report of Scrutinizer on remote e-voting and electronic voting during the Annual General Meeting (AGM) pursuant to the provisions of Section 108 of the Companies Act, 2013 and Rule 20 of the Companies (Management and Administration) Rules, 2014, for the 43 Annual General Meeting of Natco Pharma Limited held on Wednesday the 30 day of September, 2026 at 11 :00 a.m. IST through Video Conferencing (VC) I Other Audio -Visual Means ('OA VM') (collectively referred as 'VC'). I, CS Kiran Kumar Bodla, (CP No. 15876), Proprietor, Mis. BK & Associates, Practicing Company Secretaries, Hyderabad has been appointed as the Scrutinizer by the Board of Directors of the Natco Pharma Limited (CIN: L24230TG1981PLC003201) for the purposes of scrutinizing the remote e-voting and e-voting process during the AGM pursuant to Section 108 of the Companies Act, 2013 read with Rule 20 & Rule 21 of the Companies (Management and Administration) Rules, 2014 in respect of the resolutions proposed at the 43 Annual General Meeting (AGM) of Natco Pharma Limited (the "Company") held on Wednesday, 30 September, 2026 at 11.00 a.m. through VCIOAVM, and also for ascertaining [Showing first 8,000 characters — download PDF for full document]